V
Valar Labs
Offers assistance services for cancer treatment through Artificial Intelligence
About Valar Labs
Valar Labs operates at the intersection of artificial intelligence (AI) and oncology, focusing on reducing uncertainty in cancer treatment decisions. The company provides AI-driven diagnostic tests that analyze pathology slides to predict how tumors will respond to various treatments. This helps oncologists and patients make more informed decisions about therapy options. Valar Labs primarily serves oncologists and their patients, operating within the precision oncology market. The business model revolves around the development and sale of diagnostic tests, such as Vesta, the world's first AI test for predicting treatment response in bladder cancer. Revenue is generated through the sale of these diagnostic tests to healthcare providers and institutions. The company recently secured $22 million in Series A funding to advance its AI technology and expand its applications to other types of cancer.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Palo Alto, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 84.4/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Biotechnology, Oncology, Biomarkers, Core AI, Precision Medicine, Health Diagnostics, Spinout, Clinical Decision Support
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $22M | $88M | Andreessen Horowitz · Pear Ventures · DCVC | ↗ |
| SEED✓Equity / VC | Apr 2022 | $4M | $16M | Per Båtelson · Dave King · Saharsh Patel · Monishika Gupta | ↗ |
Growth signals
Latest recorded traffic for Valar Labs is 6.8K monthly website visits, up 47.8% over the last three months. Valar Labs's team grew 15.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed18 investors entered at this stage
Pear Ventures
Andreessen Horowitz- PBPer Båtelson
- DKDave King
- SPSaharsh Patel
- MGMonishika Gupta
Charles Campbell Roberts- ANArif Nathoo
- PSPeer Schatz
Nikita Andersson
Steve Blank
Johannes Schildt
Andy Palmer
Web Sun.- MRMaria Rankka
Ahsan Amjad- CMCavin Mozarmi
Devin Carty
Series A1 investor entered at this stage
Other known investors3 additional known investors
Stanford University
Koa Labs
SaxeCap
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Valar Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Valar Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.